Cytos Biotechnology Ltd Nominates Dr. Christian Itin

Dr. Itin age 48 yrs is the former President and Chief Executive Officer of Micromet Inc., a formerly Nasdaq listed biopharmaceutical company, with headquarters in Rockville, MD and a R&D center in Munich, Germany, which was acquired in March 2012 by Amgen, Inc. for USD 1.16 billion in cash. He spent 13 years with Micromet in a number of senior management roles, becoming CEO in 2004. Prior to joining Micromet in 1999, Dr. Itin co founded Zyomyx, Inc., a protein chip company based in Hayward, CA, USA.

Dr. Itin received a diploma in biology and a Ph.D. in cell biology from the University of Basel. In addition, he performed post doctoral research at the Biocenter of Basel University and at the Stanford University School of Medicine. Thomas Hecht, Chairman of Cytos, said: “Christian is an experienced biotech entrepreneur with significant expertise and a strong track record in areas such as R&D strategy, corporate, business and product development. These attributes are extremely important to Cytos as Cytos is looking to build significant value from its Immunodrug™ platform following its recent CHF 33.5 million (USD 36.2 million) financing round. We are looking forward to Christian’s contributions to Cytos’ growth and future success.”

Christian Itin, commented: “Over recent months, Cytos has established a strong foundation on which to build an exciting company based on CYT003, a novel potentially diseasemodifying approach to asthma and also on its unique Immunodrug platform. I believe the Company has a promising future and I am very pleased to have the opportunity to support its growth and development.”

media contact:
Cytos Biotechnology AG Wagistrasse 25 mailbox 8952 Schlieren Switzerland Tel: +41 44 733 47 47 Fax: +41 44 733 47 40

Editor's note: Image rights belong to the respective publisher.